3. NOAC Studies in VTE

5. AF Studies Superior Outcomes

6. Meta-analysis VTE Studies Safety Outcomes Favor NOACs vs VKA

7. Hokusai

9. What’s New in the 2014 ESC PE Guidelines?

10. Prognostic Assessment of Patients With Acute PE

11. Acute PE: Based on Early (intermediate) Mortality Risk Risk Parameters and Scores

12. ESC 2014 PE Anticoagulation Recommendations

13. Extended Treatment of VTE With NOACs

14. ESC 2014 Guideline Recommendations for Extended Treatment Using NOACs

15. Chronic Thromboembolic Pulmonary Hypertension

16. Recommendations for the Management of PE in Pregnancy and PE in Patients With Cancer